396 related articles for article (PubMed ID: 24164374)
21. Preparation of thyroid FNA material for routine cytology and BRAF testing: a validation study.
Troncone G; Cozzolino I; Fedele M; Malapelle U; Palombini L
Diagn Cytopathol; 2010 Mar; 38(3):172-6. PubMed ID: 19693938
[TBL] [Abstract][Full Text] [Related]
22. Preoperative detection of malignancy in fine-needle aspiration cytology (FNAC) smears with indeterminate cytology (Bethesda III, IV) by a combined molecular classifier.
Titov S; Demenkov PS; Lukyanov SA; Sergiyko SV; Katanyan GA; Veryaskina YA; Ivanov MK
J Clin Pathol; 2020 Nov; 73(11):722-727. PubMed ID: 32213552
[TBL] [Abstract][Full Text] [Related]
23. Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules.
Kim SK; Kim DL; Han HS; Kim WS; Kim SJ; Moon WJ; Oh SY; Hwang TS
Diagn Mol Pathol; 2008 Jun; 17(2):118-25. PubMed ID: 18382358
[TBL] [Abstract][Full Text] [Related]
24. Allele-specific PCR with competitive probe blocking for sensitive and specific detection of BRAF V600E in thyroid fine-needle aspiration specimens.
Smith GD; Zhou L; Rowe LR; Jarboe EA; Collins BT; Bentz JS; Wittwer CT; Chadwick BE
Acta Cytol; 2011; 55(6):576-83. PubMed ID: 22156469
[TBL] [Abstract][Full Text] [Related]
25. Impact of different methodologies on the detection of point mutations in routine air-dried fine needle aspiration (FNA) smears.
Rehfeld C; Münz S; Krogdahl A; Jensen EM; Siebolts U; Ferraz C; Bösenberg E; Hegedüs L; Paschke R; Eszlinger M
Horm Metab Res; 2013 Jul; 45(7):513-7. PubMed ID: 23508716
[TBL] [Abstract][Full Text] [Related]
26. BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma.
Rossi ED; Martini M; Capodimonti S; Lombardi CP; Pontecorvi A; Vellone VG; Zannoni GF; Larocca LM; Fadda G
Cancer Cytopathol; 2013 Jun; 121(6):291-7. PubMed ID: 23192956
[TBL] [Abstract][Full Text] [Related]
27. BRAF V600E detection in cytological thyroid samples: A key component of the decision tree for surgical treatment of papillary thyroid carcinoma.
Collet JF; Lacave R; Hugonin S; Poulot V; Tassart M; Fajac A
Head Neck; 2016 Jul; 38(7):1017-21. PubMed ID: 26854757
[TBL] [Abstract][Full Text] [Related]
28. Detection of BRAF mutations on direct smears of thyroid fine-needle aspirates through cell transfer technique.
Shi Q; Ibrahim A; Herbert K; Carvin M; Randolph M; Post KM; Curless K; Chen S; Cramer HM; Cheng L; Wu HH
Am J Clin Pathol; 2015 Apr; 143(4):500-4. PubMed ID: 25780001
[TBL] [Abstract][Full Text] [Related]
29. Molecular testing of BRAF, RAS and TERT on thyroid FNAs with indeterminate cytology improves diagnostic accuracy.
Decaussin-Petrucci M; Descotes F; Depaepe L; Lapras V; Denier ML; Borson-Chazot F; Lifante JC; Lopez J
Cytopathology; 2017 Dec; 28(6):482-487. PubMed ID: 29094776
[TBL] [Abstract][Full Text] [Related]
30. Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: a prospective study.
Adeniran AJ; Theoharis C; Hui P; Prasad ML; Hammers L; Carling T; Udelsman R; Chhieng DC
Thyroid; 2011 Jul; 21(7):717-23. PubMed ID: 21568726
[TBL] [Abstract][Full Text] [Related]
31. Fine-needle aspiration of the thyroid: correlating suspicious cytology results with histological outcomes.
Baynes AL; Del Rio A; McLean C; Grodski S; Yeung MJ; Johnson WR; Serpell JW
Ann Surg Oncol; 2014 May; 21(5):1653-8. PubMed ID: 24390657
[TBL] [Abstract][Full Text] [Related]
32. Assessment of cellularity, genomic DNA yields, and technical platforms for BRAF mutational testing in thyroid fine-needle aspirate samples.
Dyhdalo K; Macnamara S; Brainard J; Underwood D; Tubbs R; Yang B
Cancer Cytopathol; 2014 Feb; 122(2):114-22. PubMed ID: 24150898
[TBL] [Abstract][Full Text] [Related]
33. The mutational analysis in the diagnostic work-up of thyroid nodules: the real impact in a center with large experience in thyroid cytopathology.
Macerola E; Rago T; Proietti A; Basolo F; Vitti P
J Endocrinol Invest; 2019 Feb; 42(2):157-166. PubMed ID: 29704233
[TBL] [Abstract][Full Text] [Related]
34. BRAF V600E mutation analysis of thyroid nodules needle aspirates in relation to their ultrasongraphic classification: a potential guide for selection of samples for molecular analysis.
Nam SY; Han BK; Ko EY; Kang SS; Hahn SY; Hwang JY; Nam MY; Kim JW; Chung JH; Oh YL; Shin JH
Thyroid; 2010 Mar; 20(3):273-9. PubMed ID: 20187782
[TBL] [Abstract][Full Text] [Related]
35. Use of molecular biomarkers in FNA specimens to personalize treatment for thyroid surgery.
Mehta V; Nikiforov YE; Ferris RL
Head Neck; 2013 Oct; 35(10):1499-506. PubMed ID: 22972563
[TBL] [Abstract][Full Text] [Related]
36. Initial clinical experience with BRAF(V600E) mutation analysis of core-needle biopsy specimens from thyroid nodules.
Choi SH; Baek JH; Lee JH; Choi YJ; Ha EJ; Song DE; Kim JK; Chung KW; Kim TY; Kim WB; Shong YK
Clin Endocrinol (Oxf); 2016 Apr; 84(4):607-13. PubMed ID: 26215382
[TBL] [Abstract][Full Text] [Related]
37. Molecular characterization of 54 cases of false-negative fine-needle aspiration among 1347 papillary thyroid carcinomas.
Proietti A; Borrelli N; Giannini R; Romani R; Di Coscio G; Quilici F; Rago T; Miccoli P; Vitti P; Basolo F
Cancer Cytopathol; 2014 Oct; 122(10):751-9. PubMed ID: 24913568
[TBL] [Abstract][Full Text] [Related]
38. BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinoma.
Ohori NP; Singhal R; Nikiforova MN; Yip L; Schoedel KE; Coyne C; McCoy KL; LeBeau SO; Hodak SP; Carty SE; Nikiforov YE
Cancer Cytopathol; 2013 Apr; 121(4):197-205. PubMed ID: 22887810
[TBL] [Abstract][Full Text] [Related]
39. Malignant risk stratification of thyroid FNA specimens with indeterminate cytology based on molecular testing.
Paskaš S; Janković J; Živaljević V; Tatić S; Božić V; Nikolić A; Radojković D; Savin S; Cvejić D
Cancer Cytopathol; 2015 Aug; 123(8):471-9. PubMed ID: 25924719
[TBL] [Abstract][Full Text] [Related]
40. Indeterminate Single Thyroid Nodule: Synergistic Impact of Mutational Markers and Sonographic Features in Triaging Patients to Appropriate Surgery.
De Napoli L; Bakkar S; Ambrosini CE; Materazzi G; Proietti A; Macerola E; Basolo F; Miccoli P
Thyroid; 2016 Mar; 26(3):390-4. PubMed ID: 26548748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]